Cite
HARVARD Citation
Shields, R. et al. (n.d.). 2438. Ceftolozane/Tazobactam (C/T) Against Multidrug-Resistant Pseudomonas aeruginosa (MDR-Pa) Infections: Clinical Efficacy, and Baseline and Emergent Resistance. Open forum infectious diseases. p. S729. [Online].